Daily Brief China: Mech-Mind Robotics Technologies, Alibaba, Yadea, Nongfu Spring, Shenzhen Longsys Electronics, Shenzhen Forms Syntron Inf-A, Zylox-Tonbridge Medical Technology, WuXi XDC, ATRenew and more

• Mech Mind launched Hongkong IPO to raise nearly HK$ 2.4B. They provide intelligent robot components, with their products deployed in equipment used in end customers’ production and operational processes.
• Mech Mind intends to use the proceeds for research and development, enrich product portfolio, expand global presence, expand production capacity and for general corporate purpose.
• Technological prowess, R&D and production capabilities and supply chain efficiency of the company does make this issue fundamentally worth for investors with a long-term investment horizon.

• Alibaba (9988 HK) dropped 9.4% following its HKD 80bn placement, although the capital raising represents only 3.6% of market capitalisation and will fund AI investment.
• One-Month implied volatility stands at 42.3%, in its 67th percentile, creating elevated—but not extreme—premium income opportunities.
• September short puts offer premiums ranging from 1.3% to 4.1%, with lower strikes providing greater downside protection and higher strikes offering greater tactical returns.

• In this insight, we discuss the key reasons which led Yadea (1585 HK) to poor results in H1FY2026.
• We also discuss the outlook for H22026 and key risks to it.
• Finally, we discuss on valuation and our view on the company.

• Total revenue grew by 16% YoY and tea revenue grow by 30% in 1H26.
• The gross margin is about 61%, only next to Coca-Cola.
• We believe the stock has an upside of 28% for the year end 2027.

• Longsys’ record-breaking H1 2026 net profit of RMB 10.58 billion is a transient “inventory dividend” driven by low-cost stockpiles meeting peak market contract prices; as memory price growth slows to 10–15% in Q3 2026, the company faces a severe margin compression risk in 2027 as cheap inventory is fully depleted.
• The massive operating cash outflow of RMB 3.15 billion in H1 2026 reflects a structural working capital squeeze, driven by a 439% increase in wafer prepayments demanded by top-tier foundries to secure allocation, forcing Longsys to seek a $500 million H-share listing in Hong Kong as a critical funding lifeline to manage its $1.2 billion net debt.
• While vertical integration via the 70% acquisition of Powertech Technology Suzhou (rebranded as Longforce Suzhou) has successfully scaled local assembly, Longsys’ proprietary controller technology remains low-to-mid tier compared to Phison, and their strategic joint venture with Kingston has stalled, limiting their win/loss ratio in stickier Tier-1 enterprise accounts.

• Forms Syntron has been deeply involved in core projects of Hong Kong’s digital financial infrastructure.The Company has established a profound trust barrier within the Hong Kong digital financial regulatory framework.
• Improvement in gross margin and quarterly fluctuations coexist. Revenue recognition method that combines material cost estimation with project-based system leads to a phased imbalance in revenue rhythm and profit distribution.
• The valuation of the fintech/software services sector in the Hong Kong stock market is significantly lower than that in the A-share market. A neutral scenario could be P/E of 30-35x.

• Zylox Tonbridge Medical (2190 HK) achieved a revenue of RMB 632M, up 31% YoY, primarily attributable to the high sales growth of both neurovascular and peripheral vascular interventional devices segments. 
• In 1H26, Zylox achieved success in international business with a revenue of RMB 70.6M, up 349%, primarily from Europe, Asian and Latin American regions.
• The global growth prospects will provide the required positive impetus going forward. We feel the stock has ample room for growth and value appreciation left within.

• Shenzhen Longsys Electronics (LNGS HK / 301308 SZ) is the world’s second-largest independent semiconductor memory enterprise and China’s largest, holding a 1.2% global memory product market share across comprehensive NAND Flash and DRAM product lines.
• The company possesses a defensible multi-brand architecture—FORESEE (global B2B/industrial), Lexar (tier-1 global consumer retail), and Zilia (market leader in Latin America)—underpinned by vertically integrated in-house controller IC design, proprietary firmware, and advanced System-in-Package (SiP) backend manufacturing capabilities.
• Benefiting from the structural upcycle in memory pricing, accelerating AI edge device penetration, and enterprise SSD/server DRAM adoption, Longsys has demonstrated explosive earnings expansion (1H 2026 revenue of RMB 24.09B, up 136.3% YoY, with net profit attributable to shareholders reaching RMB 10.58B), while its dual A+H listing enhances global capital access and supply chain internationalization.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• 1H26 revenue up 37% YoY to RMB3.7bn and adjusted net profit was up 37% YoY to RMB1.0bn. Revenue mix (Pre/Post-IND) remained stable. 51 newly signed iCMC projects (record-high).
• 1H26 results call: management takeaways focus on 1) GPM outlook, 2) Singapore site utilisation ramp-up, 3) BioDlink integration, 4) commentary on project funnel, backlog growth, and 2026 guidance.
• At ~HK$78, the stock is currently trading at ~45/37x 2026E P/E (per our back-of-envelop estimates on IFRS and adjusted EPS basis). See inside for call takeaways and financial analysis.

• Higher memory costs remain the primary storyline in the world of consumer electronics.
• Higher memory costs and supply disruptions have led to price increases from many consumer electronics OEMs. Higher prices for new handsets have negatively impacted demand for new devices but have increased demand in the secondary market, where ATRenew operates.
• ATRenew continues to explore new business lines and service models to increase brand awareness and increase the percentage of customer spending it can capture.